HCM · LONDON STOCK EXCHANGE ·
HUTCHMED China Ltd
Sovleplenib Granted FDA Orphan Drug Designation
Our AI’s take
HUTCHMED reports that the US FDA has granted orphan drug designation to sovleplenib for AIHA.
The full digestion is for members. What is good, what is bad and why, the numbers that matter, and the chart, then ask about it by voice or text.
Join freeNew to announcements? Learn what an RNS is and why prices move.